Implantation of a Novel Allogeneic Mesenchymal Precursor Cell Type in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting: an Open Label Phase IIa Trial.
about
Implantation of a Novel Allogeneic Mesenchymal Precursor Cell Type in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting: an Open Label Phase IIa Trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Implantation of a Novel Alloge ...... an Open Label Phase IIa Trial.
@en
Implantation of a Novel Alloge ...... an Open Label Phase IIa Trial.
@nl
type
label
Implantation of a Novel Alloge ...... an Open Label Phase IIa Trial.
@en
Implantation of a Novel Alloge ...... an Open Label Phase IIa Trial.
@nl
prefLabel
Implantation of a Novel Alloge ...... an Open Label Phase IIa Trial.
@en
Implantation of a Novel Alloge ...... an Open Label Phase IIa Trial.
@nl
P2093
P2860
P1476
Implantation of a Novel Alloge ...... an Open Label Phase IIa Trial.
@en
P2093
Ajan Reginald
Argirios Doumas
George Efthimiadis
Kyriakos Anastasiadis
Martin John Evans
Polychronis Antonitsis
Sabena Sultan
Stephen Westaby
P2860
P2888
P304
P356
10.1007/S12265-016-9686-0
P407
P577
2016-04-01T00:00:00Z